# ScoreItem: ECG - Cornell Voltage - Mulheres (R aVL + S V3)

**ID:** `c77cedd3-2800-724c-9f1d-bfbd9472558a`
**FullName:** ECG - Cornell Voltage - Mulheres (R aVL + S V3) (Exames - Imagem)
**Unit:** mm
**Gender:** female

**Preparation Metadata:**
- Quality Grade: **GOOD**
- Total Chunks: 30 de 14 artigos
- Avg Similarity: 0.530

---

## Contexto

Voc√™ √© um especialista em medicina funcional integrativa e est√° contribuindo com o **Escore Plenya** ‚Äî um escore completo de an√°lise de sa√∫de que avalia todos os aspectos da sa√∫de, performance e longevidade humana. Cada ScoreItem representa um par√¢metro cl√≠nico, laboratorial, gen√©tico, comportamental ou hist√≥rico que comp√µe esse escore.

Seu papel √© gerar conte√∫do cl√≠nico de alta qualidade para enriquecer cada par√¢metro do escore com relev√¢ncia cl√≠nica, orienta√ß√£o ao paciente e conduta pr√°tica.

**Regras inegoci√°veis:**
- Use **apenas** o conhecimento m√©dico real consolidado e os dados presentes nos chunks cient√≠ficos abaixo
- **N√£o alucine, n√£o invente** dados, estudos, estat√≠sticas ou refer√™ncias que n√£o estejam nos chunks ou no seu conhecimento m√©dico estabelecido
- Se um dado espec√≠fico n√£o constar nos chunks e n√£o for do seu conhecimento consolidado, **n√£o o inclua**
- Seja preciso: prefira omitir a inventar

## Instru√ß√£o

Com base nos chunks cient√≠ficos abaixo, gere as respostas em formato JSON.

**O JSON deve obrigatoriamente conter o campo `score_item_id` com o valor `c77cedd3-2800-724c-9f1d-bfbd9472558a`.**

```json
{
  "score_item_id": "c77cedd3-2800-724c-9f1d-bfbd9472558a",
  "clinical_relevance": "Texto t√©cnico para m√©dicos (1000-5000 chars): defini√ß√£o fisiol√≥gica precisa, valores de refer√™ncia e interpreta√ß√£o, fisiopatologia resumida, dados epidemiol√≥gicos com n√∫meros concretos, estratifica√ß√£o de risco baseada em evid√™ncias.",
  "points": 1,
  "patient_explanation": "Texto simples para pacientes (500-1000 chars): o que √© este par√¢metro sem jarg√µes, por que √© importante para a sa√∫de, o que valores alterados podem significar. Tom tranquilizador e educativo.",
  "conduct": "Conduta cl√≠nica em Markdown (1000-5000 chars): investiga√ß√£o complementar necess√°ria, crit√©rios de encaminhamento a especialistas, interven√ß√µes baseadas em evid√™ncias. Use bullet points, se√ß√µes e negrito."
}
```

**Regras para `points` (1-50):**
- Baixo impacto cl√≠nico: 1-9 pts
- Alto impacto cl√≠nico: 10-19 pts
- Alto impacto em mortalidade: 20-50 pts
- Crit√©rios: gravidade/mortalidade (40%), preval√™ncia (30%), intervencionabilidade (30%)

---

### Contexto Cient√≠fico

**ScoreItem:** ECG - Cornell Voltage - Mulheres (R aVL + S V3) (Exames - Imagem)
**Unidade:** mm
**G√™nero:** female

**30 chunks de 14 artigos (avg similarity: 0.530)**

### Chunk 1/30
**Article:** Left ventricular hypertrophy determined by Sokolow-Lyon criteria: a different predictor in women than in men? (2006)
**Journal:** Journal of Human Hypertension
**Section:** abstract | **Similarity:** 0.673

This prospective study examined 3,338 women and 3,330 men with hypertension over 11.2 years to assess whether ECG left ventricular hypertrophy (LVH) by Sokolow-Lyon voltage criteria predicted cardiovascular outcomes differently by gender. Increasing voltage independently predicted CVD mortality in both men and women. The risk of stroke, coronary heart disease (CHD) and cardiovascular disease (CVD) mortality increased significantly for each quantitative 0.1 mV increase in baseline ECG voltage, in women within the range of 1.6-3.9% and in men 1.4-3.0%. Women tended to have a high risk of stroke mortality owing to LVH, while men demonstrated stronger associations between voltage and coronary heart disease mortality.

---

### Chunk 2/30
**Article:** Predictive value of electrocardiographic left ventricular hypertrophy in the general population: A meta-analysis (2020)
**Journal:** Journal of Electrocardiology
**Section:** abstract | **Similarity:** 0.657

This meta-analysis examined electrocardiographic left ventricular hypertrophy (LVH) as a predictor of adverse cardiac outcomes in 58,400 participants across 10 studies. The Sokolow-Lyon voltage, Cornell voltage, and Cornell product criteria showed comparable ability in predicting major adverse cardiovascular events (MACE), with risk ratios ranging from 1.56 to 1.70. The pooled risk ratio of MACE was 1.62 (95% CI 1.40-1.89) for Sokolow-Lyon voltage criteria. The pooled risk ratio of all-cause mortality was 1.47 (95% CI 1.10-1.97), and cardiovascular mortality was 1.38 (95% CI 1.19-1.60) for Sokolow-Lyon criteria. Cornell voltage demonstrated stronger predictive value for cardiovascular and all-cause mortality outcomes.

---

### Chunk 3/30
**Article:** Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography (2015)
**Journal:** Journal of the American Society of Echocardiography
**Section:** abstract | **Similarity:** 0.584

Updated guidelines for echocardiographic assessment. Normal LVEF ‚â•54% in women by Simpson method. Sex-specific reference ranges are essential for accurate diagnosis of systolic dysfunction.

---

### Chunk 4/30
**Article:** Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome (2019)
**Journal:** Journal of the American College of Cardiology
**Section:** results | **Similarity:** 0.576

dline).Patientsaregroupedaccordingtowhethermyocardialinjurywaspresent(red)orabsent(gray).Pairedlog-ranktestresultsarep¬º0.40forwomenwithmyocardialinjuryandp¬º0.08forwomenwithoutmyocardialinjury.JACCVOL.74,NO.16,2019Leeetal.OCTOBER22,2019:2032‚Äì43Sex-SpecicThresholdsofhs-cTnI2039

infarctioninwomenandmen(15).Theimpactofsex-specicthresholdsonthediagnosisofmyocardialinfarctionhasbeenevaluatedinanumberofobser-vationalstudieswithdivergentndings(7,16‚Äì20).Mostofthesestudiesenrolledselectedpatientswith
acutecoronarysyndrome,ofwhomthemajoritywere
men.Furthermore,sex-specicthresholdswerenotusedtoguideclinicalcareorsubsequentinvestiga-
tionforcoronaryarterydisease.Here,weimple-
mentedsex-specicthresholdsintoroutineclinicalcareinarandomizedcontrolledtrialandevaluatedtheirimpactinconsecutivepatientspresentingwith
suspectedacutecoronarysyndrome.Wefoundthat
useofsex-specicthresholdsidentiedproportion-atelymorewomen,suchthattheoverallpercentages
ofwomenandmenidentiedashavingmyocardialinjury

---

### Chunk 5/30
**Article:** Hipertens√£o Arterial Sist√™mica II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.553

il√¢ncia aumentada nas mulheres.**
- Pr√©-menopausa: incid√™ncia de eventos cardiovasculares em mulheres √© muito menor (raz√µes 1:20 a 1:30 versus homens).
- P√≥s-menopausa: aproxima√ß√£o para quase 1:1, refletindo a perda do efeito protetor do estrog√™nio e a mudan√ßa no perfil de risco.
**Additional Key Findings**
- Limiares de exposi√ß√£o/oxida√ß√£o do LDL: acima de 0,8 h√° maior exposi√ß√£o do LDL √† oxida√ß√£o; alvo desej√°vel ‚â§0,7‚Äì0,8.
- Evid√™ncia hist√≥rica (Interarte, 2004) e revis√µes recentes (2023) sustentam a evolu√ß√£o do conhecimento sobre D, resist√™ncia √† insulina e risco cardiovascular.
- Lp(a) tem ~90% de variabilidade gen√©tica, indicando forte determina√ß√£o heredit√°ria e necessidade de estrat√©gias espec√≠ficas.
- Semaglutida em IC diast√≥lica e obesidade: estudo com n=529 mostrou redu√ß√£o de peso de 10% e apenas 1 evento de morte por IC no grupo tratado, sugerindo benef√≠cio cl√≠nico.

---

### Chunk 6/30
**Article:** Sex-Specific Reference Values for Left Ventricular Ejection Fraction in Heart Failure: The MAGGIC Meta-Analysis (2013)
**Journal:** Circulation
**Section:** abstract | **Similarity:** 0.547

Women with heart failure have higher LVEF than men. Sex-specific cutoffs improve HFpEF vs HFrEF classification. Women have better outcomes at equivalent LVEF values compared to men.

---

### Chunk 7/30
**Article:** Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.545

fortheman-
agementofheartfailure:Areportof
theAmericanCollegeofCardiologyFoundation/AmericanHeartAssociationtaskforceonpracticeguidelines.JAmCollCardiol.2013;62:e147‚Äìe239.3.BealeAL,MeyerP,MarwickTH,LamCSP,KayeDM.Sexdifferencesincardio-vascularpathophysiology:Whywomen
areoverrepresentedinheartfailurewith
preservedejectionfraction.Circulation.2018;138:198‚Äì205.4.ShahKS,XuH,MatsouakaRA,BhattDL,HeidenreichPA,HernandezAF,Devore
AD,YancyCW,FonarowGC.Heartfail-urewithpreserved,borderline,andre-ducedejectionfraction:5-yearout-
comes.JAmCollCardiol.2017;70:2476‚Äì2486.5.HsichEM,Grau-SepulvedaMV,HernandezAF,PetersonED,Schwamm
LH,BhattDL,FonarowGC.Sex
differencesinin-hospitalmortalityinacutedecompensatedheartfailurewithreducedandpreservedejection
fraction.AmHeartJ.2012;163:430‚Äì437.e3.6.CittadiniA,SalzanoA,IacovielloM,TriggianiV,RengoG,CacciatoreF,
MaielloC,LimongelliG,MasaroneD,
PerticoneF,CimellaroA,PerroneFilardiP,PaolilloS,ManciniA,VolterraniM,VrizO,CastelloR,PassantinoA,Campo
M,ModestiPA

---

### Chunk 8/30
**Article:** Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome (2019)
**Journal:** Journal of the American College of Cardiology
**Section:** results | **Similarity:** 0.539

gnostics,andSingulex.All
otherauthorshavereportedthattheyhavenorelationshipsrelevanttothecontentsofthispapertodisclose.ManuscriptreceivedJuly11,2019;revisedmanuscriptreceivedJuly25,2019,acceptedJuly28,2019.JACCVOL.74,NO.16,2019Leeetal.OCTOBER22,2019:2032‚Äì43Sex-SpecicThresholdsofhs-cTnI2033

internationalguidelinesinuseduringenrollment(9,10).Throughoutthedurationofthetrial,allsitesmeasuredcardiactroponinusingboththecTnIand
hs-cTnIassayssimultaneously.Duringthevalidation
phase,onlytheresultsofthecTnIassaywerere-portedtotheattendingclinician,whileduringtheimplementationphase,onlytheresultsofthehs-cTnIassaywerereported.ThecTnIassay(ARCHITECTSTATtroponinIassay;AbbottLaboratories,AbbottPark,Illinois)with
asinglediagnosticthresholdforwomenandmen
wasusedtoguideclinicaldecisionsduringthevali-
dationphase.Theinterassaycoefcientofvariationwas<10%at40ng/lat7sitesand50ng/lat3sites,andtheseconcentrationswereusedasthediagnostic
thresholdsduringthevalidationphase(11).Duringtheimplementationphase,a

---

### Chunk 9/30
**Article:** Confounders in Identification and Analysis of Inflammatory Biomarkers in Cardiovascular Diseases (2026)
**Journal:** Revista n√£o identificada
**Section:** results | **Similarity:** 0.537

atherosclerosis:Resultsfromaprospective,parallel-groupcohortstudy.Clin.Chim.Acta2015,447,16‚Äì22.[CrossRef]101.Hijazi,Z.;Lindahl,B.;Oldgren,J.;Andersson,U.;Lindb√§ck,J.;Granger,C.B.;Alexander,J.H.;Gersh,B.J.;Hanna,M.;Harjola,V.;etal.RepeatedMeasurementsofCardiacBiomarkersinAtrialFibrillationandValidationoftheABCStrokeScoreOverTime.J.Am.HeartAssoc.2017,6,e004851.[CrossRef]102.Abramson,J.L.;Lewis,C.;Murrah,N.V.;Anderson,G.T.;Vaccarino,V.RelationofC-ReactiveProteinandTumorNecrosisFactor-AlphatoAmbulatoryBloodPressureVariabilityinHealthyAdults.Am.J.Cardiol.2006,98,649‚Äì652.[CrossRef]103.Simundic,A.-M.;Kackov,S.;Miler,M.;Fraser,C.G.;Petersen,P.H.TermsandSymbolsUsedinStudiesonBiologicalVariation:TheNeedforHarmonization.Clin.Chem.2015,61,438‚Äì439.[CrossRef]
	
	
Getulio Jos√© Mattos Do Amaral Filho - getfilho@yahoo.com.br - CPF: 034.983.039-88

Biomolecules2021,11,1464
17of17
104.Khuseyinova,N.;Greven,S.;R√ºckerl,R.;Trischler,G.;Loewel,H.;Peters,A.;

---

### Chunk 10/30
**Article:** Dislipidemias II (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.528

m DCV), condi√ß√µes gestacionais (pr√©-termo, hipertensivas, diabetes gestacional), autoimunidade, tratamento de c√¢ncer de mama e defici√™ncias hormonais (climat√©rio/menopausa), frequentemente subvalorizadas nos protocolos. O palestrante defende abordagem multidisciplinar e estruturada de estilo de vida, especialmente em hipertens√£o lim√≠trofe, apoiada por nutricionistas e educa√ß√£o para ades√£o.
O uso de estatinas √© discutido criticamente: reconhece-se benef√≠cio anti-inflamat√≥rio local no p√≥s-angioplastia (les√£o de parede e fragilidade do stent), por√©m questiona-se o uso indiscriminado, sobretudo em preven√ß√£o prim√°ria, citando meta-an√°lise que desafia a hip√≥tese lip√≠dica e alertando para vieses na interpreta√ß√£o de risco relativo vs. absoluto. Em UTI, menciona-se aumento de del√≠rio e a necessidade de evitar ‚Äúreceita de bolo‚Äù (anticoagula√ß√£o, IBP, estatina autom√°tica).

---

### Chunk 11/30
**Article:** Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome (2019)
**Journal:** Journal of the American College of Cardiology
**Section:** other | **Similarity:** 0.521

andsocialdeprivation.(Middle)Treatmentcommencedduringindexhospitalizationinallpatientsandstratiedbysex.(Bottom)Pre-existingtreatmentpriortoindexpresentationinallpatientsandstratiedbysex.ACE¬ºangiotensin-convertingenzyme;ARB¬ºangiotensinreceptorblocker;CI¬ºcondenceinterval;DAPT¬ºdual-antiplatelettherapy.Leeetal.JACCVOL.74,NO.16,2019Sex-SpecicThresholdsofhs-cTnIOCTOBER22,2019:2032‚Äì432038

hs-cTnIconcentrationshigherthan26ng/lbutwerelesslikelytoreceiveevidence-basedtreatment
(OnlineTables14and15).Comparedwithwomenwithhs-cTnIconcentrationshigherthan26ng/l,
womenwithhs-cTnIconcentrationsbetween16and26ng/lhadsimilarindexdiagnosesandratesoftheprimaryoutcomeat1year(13.4%[121of901]vs.

---

### Chunk 12/30
**Article:** Cardiologia VI (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.516

es com insufici√™ncia card√≠aca congestiva, conforme um estudo de 2010 com acompanhamento de 6 meses.
**A obesidade e a resist√™ncia insul√≠nica emergem como fatores de risco independentes e severos, aumentando a chance de hipertens√£o em 3,5 vezes e reduzindo a expectativa de vida em at√© 20 anos em casos de obesidade m√≥rbida.**
- Pacientes obesos com s√≠ndrome metab√≥lica apresentam um risco de mortalidade 18% maior e uma redu√ß√£o na expectativa de vida de 5 a 20 anos.
- Um estudo de 2017 mostrou que pacientes obesos com s√≠ndrome metab√≥lica t√™m 3,5 vezes mais chances de se tornarem hipertensos.
- A resist√™ncia insul√≠nica foi identificada como um fator de risco para doen√ßa cardiovascular j√° em 1996 e foi prevalente em 26% das pacientes n√£o diab√©ticas com c√¢ncer de mama em um estudo de 2012-2014 com 760 mulheres.

---

### Chunk 13/30
**Article:** Hipertens√£o Arterial Sist√™mica (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.516

a PA sist√≥lica em 5.6 mmHg e a diast√≥lica em 2.8 mmHg. Potencializa o efeito de anti-hipertensivos. A forma taurato √© a mais indicada.
*   **C√∫rcuma Longa:** Uso por mais de 12 semanas mostrou redu√ß√£o m√©dia de 8 mmHg na PA sist√≥lica.
*   **Outros:** Pot√°ssio (com cautela), quercetina, arginina, cacau, resveratrol e piquenogenol tamb√©m podem auxiliar.
*   **Abordagem Integrativa:** A suplementa√ß√£o melhora vias metab√≥licas e inflamat√≥rias, auxiliando no controle da press√£o. √â crucial saber quando usar medica√ß√£o se as metas n√£o forem atingidas apenas com estilo de vida e suplementos.
## ‚ùì Perguntas
- [Inserir Pergunta/Confus√£o]
## üìö Tarefas
- [ ] 1. Para pacientes com suspeita de hipertens√£o, solicitar MAPA ou MRPA para um diagn√≥stico preciso.
- [ ] 2. Rastrear ativamente causas de hipertens√£o secund√°ria, como apneia do sono (polissonografia) e disfun√ß√µes da tireoide (TSH).
- [ ] 3.

---

### Chunk 14/30
**Article:** Echocardiographic Reference Ranges of Global Longitudinal Strain for All Cardiac Chambers Using Guideline-Directed Dedicated Views (2024)
**Journal:** JACC: Cardiovascular Imaging
**Section:** abstract | **Similarity:** 0.516

Estudo estabeleceu valores de refer√™ncia para strain longitudinal global de todas c√¢maras card√≠acas usando imagens obtidas conforme recomenda√ß√µes da ASE/EACVI. Incluiu 1.329 participantes saud√°veis do estudo HUNT4Echo. Valores de refer√™ncia para GLS do ventr√≠culo esquerdo: -24% a -16%. Todos os strains associaram-se com idade, e GLS ventricular esquerdo associou-se com sexo. World Alliance Societies of Echocardiography prop√¥s valores normais: -17% a -24% para homens e -18% a -26% para mulheres. Define-se GLS normal como ‚â§-18% e anormal como ‚â•-16%.

---

### Chunk 15/30
**Article:** Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.514

N-terminalproB-typenatriureticpeptide;BSA,bodysurfacearea;SBP,systolicbloodpressure;DBP,diastolicbloodpressure;eGFR,estimatedglomelurarltrationrate;LAVi,leftatrialvolumeindex;e,earlydiastolictransmitralowvelocity;E‚Ä≤,earlydiastolicmitralannularvelocity;TAPSE,tricuspidannularplaneexcursion;PASP,pulmonaryarterialsystolicpressure;RVOT-AT,rightventricularoutowtractaccelerationtime;VO2peak,peakoxygenconsumption;NYHA,NewYorkHeartAssociation;AF,atrialbrillation;ACE-I,angiotensin-converting-enzymeinhibitors;ARBs,angiotensin-receptorblockers;MRA,mineralocorticoid-receptorantagonist;ICD,implantablecardioverter-debrillator;CRT,cardiacresynchronizationtherapy;IGF-1D,IGF-1deciency;DHEA-SD,DHEA-Sdeciency.

---

### Chunk 16/30
**Article:** Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome (2019)
**Journal:** Journal of the American College of Cardiology
**Section:** methods | **Similarity:** 0.513

e,high-sensitivitycardiactroponin,myocardialinfarction,sex-specicthresholdAPPENDIXForsupplementalmethods,ta-bles,andgures,andalistofHigh-STEACSinvestigators,pleaseseetheonlineversionof
thispaper.JACCVOL.74,NO.16,2019Leeetal.OCTOBER22,2019:2032‚Äì43Sex-SpecicThresholdsofhs-cTnI2043

---

### Chunk 17/30
**Article:** Dislipidemias II (2024)
**Journal:** Pos Graduacao MFI
**Section:** results | **Similarity:** 0.512

dade, inatividade f√≠sica, press√£o arterial e dislipidemia.
- A inflama√ß√£o √© indicada por marcadores como a Prote√≠na C-Reativa (PCR), onde um valor de 5 j√° √© considerado elevado, e a Interleucina 6 (exemplo de paciente com 8.45).
- A resposta anti-inflamat√≥ria √© medida pela Interleucina 10, com um valor de corte de 3,5 (abaixo disso √© um risco) e um exemplo de paciente com 6.44.
- A sa√∫de do endot√©lio √© avaliada pelo √≥xido n√≠trico, que deve estar em 8.8; um paciente com 4.8 j√° apresenta disfun√ß√£o sist√™mica.
- A LDL oxidada √© um marcador cr√≠tico, com um limite saud√°vel de 133, enquanto pacientes de alto risco podem apresentar valores extremos, como 1000.
**Achados Adicionais**
- Existem cinco par√¢metros cl√°ssicos para definir a s√≠ndrome metab√≥lica.
- O alvo de LDL para pacientes de alto risco, segundo as diretrizes atuais, √© de 50.

---

### Chunk 18/30
**Article:** Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.510

(mm/mmHg)0.63¬±0.290.53¬±0.220.68¬±0.320.008Pericardialeffusion14(15.20%)7(23.30%)7(10.93%)0.11
VO2peak(ml*kg1*min1)(n=67)20.61¬±4.7018.89¬±4.9221.31¬±4.920.03NYHAclassII66(70.21%)21(70.00%)45(70.31%)0.98III23(24.46%)7(23.33%)16(25.00%)0.87
IV5(5.33%)2(6.67%)3(4.69%)0.65Aetiology(ischaemic)27(28.7%)17(56.7%)10(15.6%)0.01Yearofdisease5[2‚Äì10.75]4[1‚Äì9.75]7[2.75‚Äì12]0.1AF11(22.4%)4(13.33%)7(10.90%)0.73
Beta-blockers66(91.7%)24(72.00%)42(65.60%)0.15
ACE-I31(43.1%)12(40.00%)19(29.70%)0.22ARBs26(36.1%)9(30.00%)17(26.60%)0.72MRA26(36.1%)8(26.70%)18(28.12%)0.88
ICD26(36.6%)8(26.66%)18(28.10%)0.88
CRT10(14.1%)1(3.33%)9(14.10%)0.15IGF-1D50(53.2%)16(53.3%)34(53.1%)0.98DHEA-SD73(77.7%)29(97.7%)44(68.7%)0.01
TypeIIdiabetes26(27.7%)6(20%)20(31.2)0.37Abbreviations:TD,testosteronedeciency;NTproBNP,N-terminalproB-typenatriureticpeptide;BSA,bodysurfacearea;SBP,systolicbloodpressure;DBP,diastolicbloodpressure;eGFR,estimatedglomelurarltrationrate;LAVi,leftatrialvolumeindex;e,earlydiastolictransmit

---

### Chunk 19/30
**Article:** Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome (2019)
**Journal:** Journal of the American College of Cardiology
**Section:** other | **Similarity:** 0.508

onalstudies,
womenaremorelikelythanmentohaveplaque
erosionsandcoronarymicroembolization(21),spontaneouscoronaryarterydissections(22),andcoronarymicrovasculardysfunction(23),andwomenareconsistentlyunderrepresentedinclinical
trialsofcardiovasculartherapies(24‚Äì26).Womenmayalsohavebeensubjectedtoclinicianbiasintheuseofdiagnostictestsorprovisionoftherapies
(27)orhavehadadisproportionateburdenofpsy-chosocialriskfactors,suchasdepressionoralack
ofsocialsupport,whichcaninuencesubsequentcardiovascularrisk(28).Shouldinternationalguidelinesrecommendtheuseofsex-specicthresholdsforthediagnosisofmyocardialinfarction?Althoughwedidnotdirectlycompareauniform99thcentilethresholdagainstthesex-specicthresholdinthistrial,ourstudydoesprovidesomehelpfulinsightsintotheuseofsex-
specicthresholds.First,useofsex-specicthresh-oldsidentiessimilarproportionsofwomenandmenpresentingwithsuspectedacutecoronarysyndromewithmyocardialinjury.Second,womenandmen
reclassiedbythehigh-sensitivityassaywithsex-specicthre

---

### Chunk 20/30
**Article:** Testosterone deficiency independently predicts mortality in women with HFrEF: insights from the T.O.S.CA. registry (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.507

riaforhearttransplantation:A
10-yearupdate.JHeartLungTransplant.2016;35:1‚Äì23.22.HarmsCA.Doesgenderaffectpulmo-naryfunctionandexercisecapacity?
RespirPhysiolNeurobiol.2006;151:124‚Äì131.23.VonkNoordegraafA,WesterhofBE,WesterhofN.Therelationshipbetween
therightventricleanditsloadinpulmo-naryhypertension.JAmCollCardiol.2017;69:236‚Äì243.24.RichterMJ,YogeswaranA,Husain-SyedF,Vad√°szI,RakoZ,MohajeraniE,GhofraniHA,NaeijeR,SeegerW,HerbergU,RiethA,TedfordRJ,
GrimmingerF,GallH,TelloK.Anovel
non-invasiveandechocardiography-derivedmethodforquanticationofrightventricularpressure-volumeloops.

---

### Chunk 21/30
**Article:** Hipertens√£o Arterial Sist√™mica (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.506

tens√£o Est√°gio 1:** 140-159 / 90-99 mmHg.
        *   **Hipertens√£o Est√°gio 2:** 160-179 / 100-109 mmHg.
        *   **Hipertens√£o Est√°gio 3:** ‚â• 180/110 mmHg.
### 3. Tratamento N√£o Farmacol√≥gico: A Base da Terapia
*   **Princ√≠pio Fundamental:** A mudan√ßa no estilo de vida √© recomendada para TODOS os est√°gios de press√£o arterial, desde o diagn√≥stico.
*   **Principais Interven√ß√µes:**
    *   **Controle de Peso:** Cada 1 kg perdido reduz a PA em 1 mmHg.
    *   **Dieta Saud√°vel:** Recomenda-se uma dieta anti-inflamat√≥ria e low-carb, que aborda a resist√™ncia insul√≠nica. Pode reduzir a PA em 3-5 mmHg.
    *   **Atividade F√≠sica:** 150 minutos de atividade aer√≥bica/semana podem reduzir a PA em 5-7 mmHg.
    *   **Redu√ß√£o do √Ålcool:** Contribui para a diminui√ß√£o da press√£o.
    *   O potencial combinado dessas mudan√ßas pode reduzir a press√£o em 30 a 40 mmHg.
*   **A Pol√™mica do S√≥dio vs.

---

### Chunk 22/30
**Article:** Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018 (2026)
**Journal:** Revista n√£o identificada
**Section:** other | **Similarity:** 0.505

rtJ.2014;35(37):2541-2619.doi:10.1093/eurheartj/ehu27876.ManciaG,FagardR,NarkiewiczK,etal.2013ESH/ESCGuidelinesfortheManagementofArterial
Hypertension:theTaskForcefortheManagement
ofArterialHypertensionoftheEuropeanSocietyof
Hypertension(ESH)andoftheEuropeanSocietyof
Cardiology(ESC).EurHeartJ.2013;34(28):2159-2219.doi:10.1093/eurheartj/eht15177.StegPG,JamesSK,AtarD,etal;TaskForceontheManagementofST-SegmentElevationAcute
MyocardialInfarctionoftheEuropeanSocietyof
Cardiology(ESC).ESCGuidelinesforthe
ManagementofAcuteMyocardialInfarctionin
PatientsPresentingWithST-SegmentElevation.EurHeartJ.2012;33(20):2569-2619.doi:10.1093/eurheartj/ehs21578.PerkJ,DeBackerG,GohlkeH,etal;EuropeanAssociationforCardiovascularPrevention&
Rehabilitation(EACPR);ESCCommitteeforPractice
Guidelines(CPG).EuropeanGuidelineson
CardiovascularDiseasePreventioninClinical
Practice(version2012).EurHeartJ.2012;33(13):1635-1701.doi:10.1093/eurheartj/ehs09279.McMurrayJJ,AdamopoulosS,AnkerSD,etal;ESCCommitteeforPracticeGuide

---

### Chunk 23/30
**Article:** Dislipidemias II (2024)
**Journal:** Pos Graduacao MFI
**Section:** discussion | **Similarity:** 0.505

√≠sica, hipertens√£o, dislipidemia).
- [ ] 3. Investigar a aplicabilidade de terapias hipolipemiantes avan√ßadas (incluindo injet√°veis de longa a√ß√£o) com an√°lise de custo-efetividade.
- [ ] 4. Mapear e discutir, em equipe, fatores adjacentes/predisponentes (inflama√ß√£o, microbiota, horm√¥nios, depress√£o, condi√ß√µes femininas espec√≠ficas) que impactam desfechos.
- [ ] 5. Elaborar plano de abordagem integrativa em cardiologia metab√≥lica, incorporando fisiopatologia da DAC e estrat√©gias al√©m dos guidelines tradicionais.
- [ ] 6. Analisar dados locais de preval√™ncia de obesidade e hipertens√£o e propor interven√ß√µes comunit√°rias e cl√≠nicas direcionadas.
- [ ] 7. Implementar abordagem multidisciplinar para hipertens√£o lim√≠trofe nos primeiros tr√™s meses, com plano estruturado de estilo de vida e suporte nutricional.
- [ ] 8.

---

### Chunk 24/30
**Article:** Hipertens√£o Arterial Sist√™mica (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.504

causa secund√°ria identific√°vel.
**O diagn√≥stico e a classifica√ß√£o da hipertens√£o seguem limiares espec√≠ficos que variam conforme o m√©todo de medi√ß√£o, com est√°gios progressivos que orientam a terapia.**
- A press√£o arterial √© classificada como √≥tima (abaixo de 120/80 mmHg), normal (at√© 129/84 mmHg) e pr√©-hipertens√£o (130-139 / 85-89 mmHg).
- O diagn√≥stico de hipertens√£o √© estabelecido a partir de 14 por 9 mmHg em medi√ß√µes de consult√≥rio, aplic√°vel a indiv√≠duos com mais de 18 anos.
- Os est√°gios da hipertens√£o s√£o definidos como: Est√°gio 1 (a partir de 14/9), Est√°gio 2 (a partir de 16/10) e Est√°gio 3 (acima de 18/11).
- Para exames fora do consult√≥rio, os limiares s√£o mais baixos: 13 por 8 mmHg para o MAPA (24 horas) e 13 por 8,5 mmHg para o MRPA.

---

### Chunk 25/30
**Article:** Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome (2019)
**Journal:** Journal of the American College of Cardiology
**Section:** results | **Similarity:** 0.503

638(45)2,472(50)1,084(52)1,388(48)2,166(40)862(42)1,304(39)Calcium-channelblocker1,977(19)921(19)397(19)524(18)1,056(19)412(20)644(19)Nicorandil645(6)303(6)149(7)154(5)342(6)174(8)168(5)
Ivabradine146(1)68(1)25(1)43(1)78(1)33(1)45(1)
Spironolactone450(4)201(4)82(4)119(4)249(4)113(5)136(4)Electrocardiographicresults¬ßNormal2,672(34)1,366(36)513(36)853(36)1,306(32)479(34)827(30)
Myocardialischemia2,510(32)1,023(27)342(24)681(28)1,487(36)445(32)1,042(38)ST-segmentelevation998(13)329(9)90(6)239(10)669(16)174(12)495(18)ST-segmentdepression1,328(17)583(16)226(16)357(15)745(18)234(17)511(18)
T-waveinversion1,277(16)640(17)252(17)388(16)637(15)232(16)405(15)Physiologicalparameters¬ßHeartrate,beats/min8626882788278826842685258326Systolicbloodpressure,mmHg13929141301402914130137281362813728GRACEriskscore14338147361483414738140391393814040HematologicandclinicalchemistrymeasurementsHemoglobin,g/l13125125241242412623137251362513725eGFR,ml/min47164616471646164915491

---

### Chunk 26/30
**Article:** EuropeanJournalofHeartFailure(2023)25,1891‚Äì1898POSITIONPAPERdoi:10.1002/ejhf.3036 (2026)
**Journal:** Revista n√£o identificada
**Section:** discussion | **Similarity:** 0.503

sensus
documentalignwiththeNICEguidelinesonchronicheartfailure,
whichrecommendacut-offvalueofNT-proBNP>2000pg/ml.40InananalysisofprimarycaredatafromEngland,anNT-proBNPvalue
of>2000pg/mlwasassociatedwithamorethantwo-foldhigherriskofheartfailurehospitalizationand50%higherriskofmortalityascomparedwithanNT-proBNPof400‚Äì2000pg/ml.47Wesug-gestthat,irrespectiveofageandsex,patientswithanNT-proBNP
>2000pg/mlshouldbeprioritizedforechocardiographyandclini-calevaluationwithin2weeksofdiagnosis(Figure2).NT-proBNPinasymptomaticpatientswithriskfactors:heart
stressVariousriskfactors,suchashypertension,atheroscleroticcardio-vasculardisease,diabetes,obesity,andothers,contributetoanincreasedsusceptibilitytothedevelopmentofheartfailure.Intheabsenceofsymptomsofheartfailure,patientswithriskfactorsmay
exhibiteitherhearthealthorheartstress.Hearthealthrefersto
individualswhohaveastructurallynormalheartandnormalplasma
concentrationsofNPsandtroponins.¬©2023EuropeanSocietyofCardiology.

---

### Chunk 27/30
**Article:** Hipertens√£o Arterial Sist√™mica II (2024)
**Journal:** Pos Graduacao MFI
**Section:** other | **Similarity:** 0.501

o cr√¥nica.
    -   Lipoprote√≠na (a) elevada, um fator de risco gen√©tico pr√≥-tromb√≥tico e pr√≥-inflamat√≥rio.
    -   Desequil√≠brios hormonais (baixo estrog√™nio e testosterona), especialmente na menopausa.
-   **Diagn√≥stico Suspeito:** Nenhum no momento
## Plano:
-   **Prescri√ß√£o:** Inserir mais aqui
-   **Pr√≥ximos Passos/Exames:**
    -   O palestrante defende uma avalia√ß√£o abrangente que vai al√©m dos fatores de risco cl√°ssicos, incluindo:
    -   Dosagem das propor√ß√µes de √îmega-3 e √îmega-6 (√çndice √îmega-3).
    -   Medi√ß√£o do Horm√¥nio D (Vitamina D), com metas de n√≠veis √≥timos (ex: >80 ng/mL para cardiopatas, controlando com PTH).
    -   Curva glic√™mica e de insulina para detectar resist√™ncia √† insulina precocemente.
    -   Avalia√ß√£o da homociste√≠na.
    -   Medi√ß√£o da lipoprote√≠na (a).
    -   Avalia√ß√£o da rela√ß√£o ApoB/ApoA.
    -   Avalia√ß√£o dos n√≠veis hormonais (testosterona, estradiol, DHEA).

---

### Chunk 28/30
**Article:** EuropeanJournalofHeartFailure(2023)25,1891‚Äì1898POSITIONPAPERdoi:10.1002/ejhf.3036 (2026)
**Journal:** Revista n√£o identificada
**Section:** discussion | **Similarity:** 0.501

from125to250pg/ml,whileforthoseover75years,itextendsfrom125to500pg/ml.Itiscrucialtoconductathoroughevaluationofpatientswithinthegreyzone,consideringfactorssuchasobesity,race-basedvariations,andongoingtreatment(asmanypatientswithahistory
ofhypertensionmayalreadybeondiuretics,renin‚Äìangiotensin
systeminhibitors,ormineralocorticoidreceptorantagonists).Intheoutpatientsetting,theextentofelevationinNPconcen-trationsatthetimeofheartfailurediagnosisiscloselylinkedtothe
riskofsubsequenthospitalizationandmortality.16Asaresult,therehasbeenasuggestiontoutilizeNT-proBNPconcentrationsatthe
timeofacommunity-basedheartfailurediagnosisasatriagingtooltoprioritizeaccesstoexpediteddiagnosticechocardiogra-phyandtosetupafollow-upplanforindividualswiththehighest
short-termriskofadverseevents.Theauthorsofthisconsensus
documentalignwiththeNICEguidelinesonchronicheartfailure,
whichrecommendacut-offvalueofNT-proBNP>2000pg/ml.40InananalysisofprimarycaredatafromEngland,anNT-proBNPvalue
of>2000pg/mlwasassociatedwi

---

### Chunk 29/30
**Article:** Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome (2019)
**Journal:** Journal of the American College of Cardiology
**Section:** other | **Similarity:** 0.500

-specic thresholds identied 5-times moreadditional women than men with myocardial injuryDespite this, women received fewer treatmentsfor coronary artery disease than men
And their outcomes were not improved.Adjusted Hazard Ratio:Women 1.11 (95% CI: 0.92 - 1.33)Men 0.85 (95% CI: 0.71 - 1.01)Coronaryrevascularization(35% versus 57%)Dual anti-platelettherapy(54% versus 67%)Women
Men
Type 1 MIType 2 MINon-ischemicmyocardialinjury
Lee,K.K.etal.JAmCollCardiol.2019;74(16):2032‚Äì43.Sex-specicthresholdsidentied5timesmoreadditionalwomenthanmenwithmyocardialinjury.Despitethis,womenreceivedfewertreatmentsforcoronaryarterydiseasethanmen,andtheiroutcomeswerenotimproved.CI¬ºcondenceinterval;MI¬ºmyocardialinfarction.Leeetal.JACCVOL.74,NO.16,2019Sex-SpecicThresholdsofhs-cTnIOCTOBER22,2019:2032‚Äì432040

cardiovasculardeathat1year(8).Here,wereporttheprimaryoutcomestratiedbysex.Thevastmajorityofpatientsreclassiedbythesex-specicthresholdswerewomen,butwedidnotobserveanyimprove-
mentintheiroutcome

---

### Chunk 30/30
**Article:** Sex-Specific Thresholds of High-Sensitivity Troponin in Patients With Suspected Acute Coronary Syndrome (2019)
**Journal:** Journal of the American College of Cardiology
**Section:** other | **Similarity:** 0.500

arfarinanddirectoralanticoagulantagents.¬ßElectrocardiographicandphysiologicaldatawereavailablein1,377ofreclassiedpatients(78%)and6,470ofidentiedpatients(75%).kDenedas2ormoretestswithin24hofpresentation.¬∂Theadjudicationpanelwasabletoachieveconsensusdiagnosesin9,098of10,360patients(88%)withhs-cTnIconcentrationsabovethesex-specic99thcentile.ACE¬ºangiotensin-convertingenzyme;ARB¬ºangiotensinreceptorblocker;CABG¬ºcoronaryarterybypassgrafting;eGFR¬ºestimatedglomerularltrationrate;GRACE¬ºGlobalRegistryofAcuteCoronaryEvents;hs-cTnI¬ºhighsensitivitycardiactroponinI;MI¬ºmyocardialinfarction;PCI¬ºpercutaneouscoronaryintervention.JACCVOL.74,NO.16,2019Leeetal.OCTOBER22,2019:2032‚Äì43Sex-SpecicThresholdsofhs-cTnI2035

menby6%(from2,904of25,078[12%]to3,018of25,078[12%])(Figure1).Theuseofanhs-cTnIassayandsex-specicthresholdsincreasedthediagnosisoftype2myocardialinfarctioninwomenby39%(from
505of21,959[2%]to700of21,959[3%])andinmen
by9%(from515of25,078[2%]to560of25,078[2%])
andincreasedthediagn

---

